Jing Cheng

机构：Union Hospital, Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Wuhan Union Hospital, Union Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-4100-5567

发表论文 65 篇 · 总被引 977 次 · h-index 17

代表论文

• Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial (2021 · Nature Medicine · 被引 176)
• Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial (2024 · Nature Medicine · 被引 120)
• Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial (2023 · BMJ · 被引 87)
• Identification and Verification of Necroptosis-Related Gene Signature and Associated Regulatory Axis in Breast Cancer (2022 · Frontiers in Genetics · 被引 37)
• Prevalence and Impact Factors of COVID-19 Vaccination Hesitancy Among Breast Cancer Survivors: A Multicenter Cross-Sectional Study in China (2021 · Frontiers in Medicine · 被引 23)
• Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023 (2024 · Frontiers in Pharmacology · 被引 18)